|
US2390529A
(en)
|
1942-02-03 |
1945-12-11 |
Ernst A H Friedheim |
Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds
|
|
US2913408A
(en)
|
1956-12-28 |
1959-11-17 |
Dow Chemical Co |
Corrosion inhibitors for ferrous metals in aqueous solutions of non-oxidizing acids
|
|
DE1252823B
(enExample)
|
1963-02-15 |
|
|
|
|
BE754242A
(fr)
|
1970-07-15 |
1971-02-01 |
Geigy Ag J R |
Diamino-s-triazines et dinitro-s-triazines
|
|
US3867383A
(en)
|
1971-03-29 |
1975-02-18 |
Ciba Geigy Corp |
Monoanthranilatoanilino-s-triazines
|
|
BE793501A
(fr)
|
1971-12-31 |
1973-06-29 |
Ciba Geigy |
Composes heterocycliques et produits phytopharmaceutiques qui en contiennent
|
|
CH606334A5
(enExample)
|
1974-06-21 |
1978-10-31 |
Ciba Geigy Ag |
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
JPS58186682A
(ja)
|
1982-04-27 |
1983-10-31 |
日本化薬株式会社 |
セルロ−ス又はセルロ−ス含有繊維材料の染色法
|
|
JPS59151784U
(ja)
|
1983-03-30 |
1984-10-11 |
日産自動車株式会社 |
トラツクのリヤボデイ構造
|
|
DE3512630A1
(de)
|
1985-04-06 |
1986-10-23 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern
|
|
US5041443A
(en)
|
1989-02-21 |
1991-08-20 |
Dainippon Pharmaceutical Co., Ltd. |
Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
|
|
DE69010232T2
(de)
|
1989-03-03 |
1994-12-01 |
Dainippon Pharmaceutical Co |
2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
|
|
JPH0499768A
(ja)
|
1990-08-17 |
1992-03-31 |
Dainippon Pharmaceut Co Ltd |
４―（４―フェニルピリジン―２―イル）ピペラジン―１―オキシド誘導体
|
|
JPH05140126A
(ja)
|
1991-11-26 |
1993-06-08 |
Hokko Chem Ind Co Ltd |
トリアゾール誘導体および除草剤
|
|
AU665238B2
(en)
|
1992-02-28 |
1995-12-21 |
Zenyaku Kogyo Kabushiki Kaisha |
S-triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient
|
|
IL115420A0
(en)
|
1994-09-26 |
1995-12-31 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
|
WO1998021191A1
(en)
|
1995-05-16 |
1998-05-22 |
Nissan Chemical Industries, Ltd. |
Cyanoethylmelamine derivatives and process for producing the same
|
|
FR2735127B1
(fr)
|
1995-06-09 |
1997-08-22 |
Pf Medicament |
Nouvelles piperazines heteroaromatiques utiles comme medicaments.
|
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
|
EP0880501A1
(en)
|
1996-02-02 |
1998-12-02 |
Zeneca Limited |
Heterocyclic compounds useful as pharmaceutical agents
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
JPH09291034A
(ja)
|
1996-02-27 |
1997-11-11 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ピリジン化合物およびその医薬としての用途
|
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
CA2252501A1
(en)
|
1996-05-20 |
1997-11-27 |
Darwin Discovery Limited |
Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
|
|
US5984882A
(en)
|
1996-08-19 |
1999-11-16 |
Angiosonics Inc. |
Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
|
|
US6399358B1
(en)
|
1997-03-31 |
2002-06-04 |
Thomas Jefferson University |
Human gene encoding human chondroitin 6-sulfotransferase
|
|
CA2290624C
(en)
|
1997-06-06 |
2006-12-05 |
John W. Shell |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
EP0901786B1
(en)
|
1997-08-11 |
2007-06-13 |
Pfizer Products Inc. |
Solid pharmaceutical dispersions with enhanced bioavailability
|
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンａ３拮抗剤
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
PT1042305E
(pt)
|
1997-12-22 |
2005-10-31 |
Bayer Pharmaceuticals Corp |
Inibicao de quinase p38 utilizando difenilureias simetricas e assimetricas
|
|
AU9064598A
(en)
|
1998-07-10 |
2000-02-01 |
Harald Groger |
Precusors for pna-monomers
|
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
|
DE69943205D1
(de)
|
1998-08-06 |
2011-03-31 |
Mountain View Pharmaceuticals |
Peg-uricase Konjugate und Verwendung davon
|
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
EP1187825A1
(en)
|
1999-06-07 |
2002-03-20 |
Shire Biochem Inc. |
Thiophene integrin inhibitors
|
|
NZ517426A
(en)
|
1999-08-27 |
2004-04-30 |
Sugen Inc |
Phosphate mimics and methods of treatment using phosphatase inhibitors
|
|
JP4744050B2
(ja)
|
1999-09-17 |
2011-08-10 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
ベンズアミドおよび関連するＸａ因子阻害剤
|
|
BR0014078A
(pt)
|
1999-09-17 |
2002-12-31 |
Millennium Pharm Inc |
Inibidores de fator xa
|
|
IL150420A0
(en)
|
1999-12-28 |
2002-12-01 |
Pharmacopeia Inc |
Pyrimidine and triazine kinase inhibitors
|
|
ES2270982T3
(es)
|
2000-02-04 |
2007-04-16 |
Depomed, Inc. |
Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
|
|
US6376515B2
(en)
|
2000-02-29 |
2002-04-23 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor Xa
|
|
JP2004525071A
(ja)
|
2000-07-20 |
2004-08-19 |
ニューロジェン コーポレイション |
カプサイシン受容体リガンド
|
|
JP4113323B2
(ja)
|
2000-08-07 |
2008-07-09 |
富士フイルム株式会社 |
アゾ色素及びそれを含むインクジェット記録用インク、並びにインクジェット記録方法
|
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
|
US20030095958A1
(en)
|
2001-04-27 |
2003-05-22 |
Bhisetti Govinda R. |
Inhibitors of bace
|
|
IL158590A0
(en)
|
2001-06-11 |
2004-05-12 |
Biovitrum Ab |
Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
|
|
JP2005500294A
(ja)
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ７に対するピリミジン阻害剤
|
|
ATE485281T1
(de)
|
2001-08-17 |
2010-11-15 |
Basf Se |
Triazinderivate und deren verwendung als sonnenschutzmittel
|
|
JP4753336B2
(ja)
|
2001-09-04 |
2011-08-24 |
日本化薬株式会社 |
新規アリル化合物及びその製法
|
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
US6878196B2
(en)
|
2002-01-15 |
2005-04-12 |
Fuji Photo Film Co., Ltd. |
Ink, ink jet recording method and azo compound
|
|
US20040067234A1
(en)
|
2002-07-11 |
2004-04-08 |
Paz Einat |
Isocitrate dehydrogenase and uses thereof
|
|
WO2004009562A1
(en)
|
2002-07-18 |
2004-01-29 |
Janssen Pharmaceutica, Nv |
Substituted triazine kinase inhibitors
|
|
JP2004083610A
(ja)
|
2002-08-22 |
2004-03-18 |
Fuji Photo Film Co Ltd |
インクセット、インクカートリッジ、記録方法、プリンター及び記録物
|
|
JP2004107220A
(ja)
|
2002-09-13 |
2004-04-08 |
Mitsubishi Pharma Corp |
ＴＮＦ−α産生抑制剤
|
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
|
AU2003293333A1
(en)
|
2002-12-02 |
2004-06-23 |
Arqule, Inc. |
Method of treating cancers
|
|
NZ541050A
(en)
|
2002-12-16 |
2010-06-25 |
Genmab As |
Human monoclonal antibodies against interleukin 8 (IL-8)
|
|
KR20050098244A
(ko)
|
2003-01-10 |
2005-10-11 |
쓰레솔드 파마슈티컬스, 인코포레이티드 |
2-데옥시글루코오스를 사용한 암 치료 방법
|
|
US7358262B2
(en)
|
2003-01-29 |
2008-04-15 |
Whitehead Institute For Biomedical Research |
Identification of genotype-selective anti-tumor agents
|
|
WO2004073619A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
|
US6887855B2
(en)
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
|
US7038038B2
(en)
|
2003-03-17 |
2006-05-02 |
Pharmion Corporation |
Synthesis of 5-azacytidine
|
|
EP1615698B1
(en)
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
New amide derivatives and pharmaceutical use thereof
|
|
EP1482418A1
(en)
|
2003-05-28 |
2004-12-01 |
Sap Ag |
A data processing method and system
|
|
AU2004263148B2
(en)
|
2003-08-06 |
2008-08-21 |
Vertex Pharmaceuticals, Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
|
US7582645B2
(en)
|
2003-10-10 |
2009-09-01 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives for treatment of hyperproliferative disorders
|
|
WO2005060956A1
(en)
|
2003-12-12 |
2005-07-07 |
University Of Maryland, Baltimore |
IMMUNOMODULATORY COMPOUNDS THAT TARGET AND INHIBIT THE pY+3 BINDING SITE OF TYROSENE KINASE p56 LCK SH2 DOMAIN
|
|
WO2005065691A1
(en)
|
2003-12-24 |
2005-07-21 |
Scios, Inc. |
Treatment of malignant gliomas with tgf-beta inhibitors
|
|
JP2005264016A
(ja)
|
2004-03-19 |
2005-09-29 |
Fuji Photo Film Co Ltd |
インクジェット記録用インク、インクセット及びインクジェット記録方法
|
|
US7335770B2
(en)
|
2004-03-24 |
2008-02-26 |
Reddy U5 Therapeutics, Inc. |
Triazine compounds and their analogs, compositions, and methods
|
|
US7192781B2
(en)
|
2004-04-13 |
2007-03-20 |
Pharmion Corporation |
Methods for stabilizing 5-azacytidine in plasma
|
|
GB0412526D0
(en)
|
2004-06-05 |
2004-07-14 |
Leuven K U Res & Dev |
Type 2 diabetes
|
|
CA2580845A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
|
CA2581454A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
Ｎ型カルシウムチャネル阻害薬
|
|
JP2008526723A
(ja)
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
|
|
BRPI0606930A2
(pt)
|
2005-01-25 |
2009-12-01 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, e, métodos para a produção de um efeito de inibição de b-raf em um animal de sangue quente, para a produção de um efeito anti-cáncer em um animal de sangue quente e para o tratamento de doenças de um animal em um animal de sangue quente
|
|
KR101304289B1
(ko)
|
2005-04-11 |
2013-09-12 |
새비언트 파마수티컬즈 인크. |
유레이트 옥시다아제의 변이형 및 이의 용도
|
|
US8278038B2
(en)
|
2005-06-08 |
2012-10-02 |
Millennium Pharmaceuticals, Inc. |
Methods for the identification, assessment, and treatment of patients with cancer therapy
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
CN101296909B
(zh)
|
2005-08-26 |
2011-10-12 |
默克雪兰诺有限公司 |
吡嗪衍生物及其作为pi3k抑制剂的应用
|
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
TW200815426A
(en)
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
|
US20100297673A1
(en)
|
2006-09-20 |
2010-11-25 |
Reddy Us Therapeutics |
Methods and compositions for upregulation of peroxiredoxin activity
|
|
US20080109846A1
(en)
|
2006-10-23 |
2008-05-08 |
Ewertz C Christian |
System and method for audiovisual content playback
|
|
CA2669117A1
(en)
|
2006-10-26 |
2008-05-02 |
Gary A. Flynn |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
HUP0600810A3
(en)
|
2006-10-27 |
2008-09-29 |
Richter Gedeon Nyrt |
New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
|
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
|
WO2008070661A1
(en)
|
2006-12-04 |
2008-06-12 |
Neurocrine Biosciences, Inc. |
Substituted pyrimidines as adenosine receptor antagonists
|
|
EP2101760B1
(en)
|
2006-12-08 |
2013-02-27 |
Millennium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
|
JP5622393B2
(ja)
|
2006-12-15 |
2014-11-12 |
アブラクシスバイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
|
CA2684968C
(en)
|
2007-04-30 |
2015-07-07 |
Prometic Biosciences Inc. |
Compounds, compositions containing such compounds, and methods of treatment of cancer and autoimmune diseases using such compounds
|
|
AU2008262291A1
(en)
|
2007-06-11 |
2008-12-18 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
|
CA2693901C
(en)
|
2007-07-20 |
2015-12-29 |
Nerviano Medical Sciences S.R.L. |
Substituted indazole derivatives active as kinase inhibitors
|
|
ES2392003T3
(es)
|
2007-07-25 |
2012-12-03 |
Bristol-Myers Squibb Company |
Inhibidores de la triazina quinasa
|
|
TW200906818A
(en)
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2008311727A1
(en)
|
2007-10-10 |
2009-04-16 |
Takeda Pharmaceutical Company Limited |
Amide compound
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
GB0805477D0
(en)
|
2008-03-26 |
2008-04-30 |
Univ Nottingham |
Pyrimidines triazines and their use as pharmaceutical agents
|
|
JP5277685B2
(ja)
|
2008-03-26 |
2013-08-28 |
富士ゼロックス株式会社 |
電子写真感光体、画像形成装置、プロセスカートリッジ及び画像形成方法
|
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
CN101575408B
(zh)
|
2008-05-09 |
2013-10-30 |
Mca技术有限公司 |
用作阻燃剂和光稳定剂的聚三嗪基化合物
|
|
EP4327888A3
(en)
*
|
2008-05-15 |
2024-05-22 |
Celgene Corporation |
Oral formulations of cytidine analogs and methods of use thereof
|
|
FR2932483A1
(fr)
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
|
WO2010007756A1
(ja)
|
2008-07-14 |
2010-01-21 |
塩野義製薬株式会社 |
Ｔｔｋ阻害作用を有するピリジン誘導体
|
|
WO2010028099A1
(en)
|
2008-09-03 |
2010-03-11 |
The Johns Hopkins University |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
|
|
WO2010028179A1
(en)
|
2008-09-03 |
2010-03-11 |
Dr. Reddy's Laboratories Ltd. |
Heterocyclic compounds as gata modulators
|
|
JP2010079130A
(ja)
|
2008-09-29 |
2010-04-08 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
|
EP2370417A2
(en)
|
2008-11-21 |
2011-10-05 |
Millennium Pharmaceuticals, Inc. |
Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
|
|
JP2010181540A
(ja)
|
2009-02-04 |
2010-08-19 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
|
AU2010211672B2
(en)
|
2009-02-06 |
2016-08-04 |
Nippon Shinyaku Co., Ltd. |
Aminopyrazine derivative and medicine
|
|
JP6067226B2
(ja)
|
2009-03-13 |
2017-01-25 |
アジオス ファーマシューティカルズ， インコーポレイテッド |
細胞増殖関連疾患のための方法および組成物
|
|
WO2010129596A1
(en)
|
2009-05-04 |
2010-11-11 |
Agios Pharmaceuticals, Inc. |
Pmk2 modulators for use in the treatment of cancer
|
|
WO2010130638A1
(en)
|
2009-05-14 |
2010-11-18 |
Evotec Ag |
Sulfonamide compounds, pharmaceutical compositions and uses thereof
|
|
EP2440050A4
(en)
|
2009-06-08 |
2013-04-03 |
California Capital Equity Llc |
TRIAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
|
|
EP2440056A4
(en)
|
2009-06-09 |
2012-12-05 |
California Capital Equity Llc |
DERIVATIVES OF UREIDOPHENYL SUBSTITUTED TRIAZINE AND THERAPEUTIC APPLICATIONS THEREOF
|
|
KR20120026611A
(ko)
|
2009-06-09 |
2012-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
헷지호그 신호전달의 피리딜-트리아진 억제제
|
|
JP5856052B2
(ja)
|
2009-06-29 |
2016-02-09 |
アジオス ファーマシューティカルズ， インコーポレイテッド |
治療化合物および組成物
|
|
EP2451402B1
(en)
|
2009-07-10 |
2016-04-27 |
Kirk Promotion LTD. |
Knee joint device
|
|
WO2011027249A2
(en)
|
2009-09-01 |
2011-03-10 |
Pfizer Inc. |
Benzimidazole derivatives
|
|
CA2773561A1
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
|
JP5473851B2
(ja)
|
2009-09-30 |
2014-04-16 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板及び液晶表示装置
|
|
US8652534B2
(en)
|
2009-10-14 |
2014-02-18 |
Berry Pharmaceuticals, LLC |
Compositions and methods for treatment of mammalian skin
|
|
CA2793835C
(en)
|
2009-10-21 |
2021-07-20 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
CN105153188B
(zh)
|
2009-10-22 |
2018-06-01 |
法博太科制药有限公司 |
抗纤维化剂的稠环类似物
|
|
ES2642109T3
(es)
|
2009-12-09 |
2017-11-15 |
Agios Pharmaceuticals, Inc. |
Compuestos terapéuticamente activos para su uso en el tratamiento de cáncer caracterizados por tener una mutación de IDH
|
|
NZ578968A
(en)
|
2010-02-10 |
2011-03-31 |
Allans Sheetmetal And Engineering Services |
Fuel feed system for a pellet fire
|
|
EP2553116A4
(en)
|
2010-04-01 |
2013-10-23 |
Agios Pharmaceuticals Inc |
METHOD FOR IDENTIFYING A CANDIDATE COMPOUND
|
|
WO2011143160A2
(en)
|
2010-05-10 |
2011-11-17 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
|
US10064885B2
(en)
|
2010-07-09 |
2018-09-04 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
|
CN103097340B
(zh)
|
2010-07-16 |
2018-03-16 |
安吉奥斯医药品有限公司 |
治疗活性组合物及其使用方法
|
|
SG10201710578TA
(en)
|
2010-10-21 |
2018-02-27 |
Medivation Technologies Inc |
Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
|
|
WO2012078288A2
(en)
|
2010-11-08 |
2012-06-14 |
Washington University |
Methods of determining risk of adverse outcomes in acute myeloid leukemia
|
|
BR112013013429A2
(pt)
|
2010-11-29 |
2017-03-21 |
Galleon Pharmaceuticals Inc |
composição, método de prevenção ou tratamento de distúrbio ou doença de controle da respiração, e, método de prevenção de desestabilização ou estabilização do ritmo respiratório
|
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
|
EP2670396A1
(en)
|
2011-01-31 |
2013-12-11 |
Celgene Corporation |
Pharmaceutical compositions of cytidine analogs and methods of use thereof
|
|
EP2691391A4
(en)
|
2011-03-29 |
2014-09-10 |
Broad Inst Inc |
COMPOUNDS AND METHODS OF TREATING DISORDERS MEDIATED BY ISOCITRATE DEHYDROGENASE
|
|
CN103608016A
(zh)
|
2011-05-03 |
2014-02-26 |
安吉奥斯医药品有限公司 |
丙酮酸激酶激活剂在治疗中的用途
|
|
TW201636330A
(zh)
|
2011-05-24 |
2016-10-16 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
JP2014522242A
(ja)
|
2011-06-06 |
2014-09-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
イソクエン酸デヒドロゲナーゼ（ｉｄｈ１）遺伝子発現のｒｎａ干渉媒介抑制
|
|
JO3410B1
(ar)
*
|
2011-06-07 |
2019-10-20 |
Otsuka Pharma Co Ltd |
تركيبة أريبيبرازول مجفف بالتبريد
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
ES2698847T3
(es)
|
2011-07-07 |
2019-02-06 |
Merck Patent Gmbh |
Azaheterociclos sustituidos para el tratamiento del cáncer
|
|
ES2627120T3
(es)
|
2011-07-08 |
2017-07-26 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Medicamento para el tratamiento del cáncer de hígado
|
|
EP2734519B1
(en)
|
2011-07-22 |
2016-05-04 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
|
CN102659765B
(zh)
|
2011-12-31 |
2014-09-10 |
沈阳药科大学 |
嘧啶及三嗪类化合物的制备方法和应用
|
|
RS57401B1
(sr)
|
2012-01-06 |
2018-09-28 |
Agios Pharmaceuticals Inc |
Terapeutski aktivna jedinjenja i postupci za njihovu upotrebu
|
|
ES2698625T3
(es)
|
2012-01-19 |
2019-02-05 |
Agios Pharmaceuticals Inc |
Compuestos terapéuticamente activos y sus métodos de uso
|
|
US9474779B2
(en)
*
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
|
EP2634259A1
(en)
|
2012-03-01 |
2013-09-04 |
Deutsches Krebsforschungszentrum |
Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG)
|
|
WO2013133367A1
(ja)
|
2012-03-09 |
2013-09-12 |
カルナバイオサイエンス株式会社 |
新規トリアジン誘導体
|
|
EP2825669A4
(en)
|
2012-03-12 |
2016-02-24 |
Sloan Kettering Inst Cancer |
METHOD AND COMPOSITIONS FOR DIAGNOSIS, FORECASTING AND TREATING ACUTE MYELOIC LEUKEMIA
|
|
WO2014015422A1
(en)
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Cellulose-based nanoparticles for drug delivery
|
|
NZ706999A
(en)
|
2012-10-15 |
2018-12-21 |
Agios Pharmaceuticals Inc |
Inhibitors of mutant isocitrate dehydrogenase and therapeutical uses thereof
|
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
WO2015127173A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
WO2015127172A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
US9968595B2
(en)
|
2014-03-14 |
2018-05-15 |
Agios Pharmaceuticals, Inc. |
Pharmaceutical compositions of therapeutically active compounds
|
|
NZ723860A
(en)
|
2014-03-14 |
2023-04-28 |
Servier Lab |
Pharmaceutical compositions of therapeutically active compounds and their uses
|
|
CN108697698B
(zh)
*
|
2015-10-15 |
2021-12-03 |
阿吉奥斯制药公司 |
用于治疗恶性肿瘤的组合疗法
|
|
SG10201912869WA
(en)
*
|
2015-10-15 |
2020-02-27 |
Celgene Corp |
Combination therapy for treating malignancies
|
|
IL258684B2
(en)
|
2015-10-15 |
2023-04-01 |
Agios Pharmaceuticals Inc |
Combination therapy including an isocitrate dehydrogenase (1idh) inhibitor for use in the treatment of acute myelogenous leukemia (aml) characterized by the presence of a mutant allele of 1idh
|
|
US20200268726A1
(en)
|
2015-12-04 |
2020-08-27 |
Agios Pharmaceuticals, Inc. |
Methods of treatment of malignancies
|
|
KR20180114202A
(ko)
|
2016-02-26 |
2018-10-17 |
아지오스 파마슈티컬스 아이엔씨. |
혈액 악성종양 및 고형 종양의 치료를 위한 idh1 억제제
|
|
CA3036384A1
(en)
*
|
2016-09-14 |
2018-03-22 |
Gilead Sciences, Inc. |
Syk inhibitors
|